EKF Diagnostics Holdings plc (EKDHF) Financiero

EKF Diagnostics Holdings Plc is a vitro diagnostics company, which engages in the designs and manufactures diagnostic equipment for use within point-of-care settings. The company is headquartered in Penarth, South Glamorgan and currently employs 300 full-time employees. The company went IPO on 2002-06-05. The firm's business is focused on point-of-care and life sciences. The firm's point-of-care analyzers are utilized worldwide, with patients benefiting from receiving rapid medical advice and diagnosis. The firm produces and distributes point-of-care medical devices and in-vitro diagnostic (IVD) tests for use at or near the patient’s location, allowing healthcare professionals to make decisions. Its point-of-care products include hemoglobin products and diabetes products. The firm's life sciences services provide specialist manufacturing of enzymes and custom products for use in diagnostic, food and industrial applications. The firm's solutions include precision fermentation, bio-processing, diagnostic enzymes, and contract reagent formulation and kitting. The company develops and provides a range of devices, tests, and media for analysis in central laboratory settings.